Samsung Biologics has signed a contract worth 111.2 billion won with an undisclosed U.S. pharmaceutical firm to provide ...

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its ...

Biomedicines ("Generate") as part of its efforts to drive growth and innovation in the biopharmaceutical sector. The ...

Samsung Biologics earns spot on Dow Jones Sustainability Index for fourth year Samsung Biologics maintains its position in ...

Samsung Group has 22 affiliates listed on the local stock market, including Samsung Electronics Co., Samsung Biologics Co., ...

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today hosted its ...

Threading quality into every step: One-stop manufacturing at Samsung Biologics Samsung Biologics, a fully integrated CDMO, is dedicated to ensuring high-quality production through its ...

The combined market capitalization of Samsung Group's affiliates dropped about 23 percent in 2024 due to the sluggish ...

Samsung invests in Generate to advance AI-driven protein therapeutics discovery: Incheon, South Korea Saturday, December 21, 2024, 17:00 Hrs [IST] Samsung announced that it has in ...